Ending clinical trials with no warning can put patients at risk.

From Phil King’s Regal Partners to Russel Pillemer’s Pengana Capital, fund managers loved vision treatment hopeful Opthea.

People are falling prey to “subscription creep,” a clever name referring to the sneaky monthly or annual fees from an array ...

Madhya Pradesh High Court allows disposal of Union Carbide waste in Pithampur after successful trials. The decision comes ...

As fears of a recession loom large, some people have begun to reevaluate their spending habits. A small but potentially ...

The four-decade-old hazardous waste shall be disposed of in a safe manner at the plant in Dhar district within 72 days, said ...

Under the theme ‘We name Bahamas’, the Bahamas Association of Athletic Associations’ (BAAA) is set to stage what is ...

Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...

Q4 2024 Management View CEO Panna Sharma highlighted 2024 as a transformational year, emphasizing the company's advancements in computational and AI-driven drug discovery, particularly in precision ...

ICOMiner ranks high among trusted cloud mining sites in 2025, offering free trials to start your cloud mining journey. Established in 2013, this platform supports Bitcoin, Litecoin, Dogecoin cloud ...

Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.

From the grounds of a gas-fired power plant on the eastern shores of Canada, a little-known company is pumping a slurry of minerals into the ocean in the name of stopping climate change. Whether it’s ...